文献速递慢性肾脏病肾血管病与高血压

代谢综合征中的肾脏疾病:肾内缺血的隐藏作用

Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia.
PubMed 文献 · Kidney Int Rep · 2024-02-22

本研究基于欧洲肾切除生物样本库(ENBiBA)项目,评估代谢综合征(MS)患者与无MS者的肾脏组织学差异。共157例(无MS 49例,MS 108例),MS患者年龄更大、CKD更常见、白蛋白肌酐比更高,且全球硬化、结节性硬化、系膜扩张、肾小球肥大、中重度玻璃样变及动脉硬化更频繁。结论提示MS中缺血性肾病可能参与肾脏疾病发生,部分患者可出现类似糖尿病肾病的病变。

要点

  • 代谢综合征患者肾脏组织学显示更频繁的全球硬化、结节性硬化、系膜扩张和肾小球肥大。
  • 代谢综合征患者中重度玻璃样变和动脉硬化更常见,且血管改变独立于年龄差异。
  • 代谢综合征患者CKD(eGFR<60 ml/min)患病率更高,白蛋白肌酐比也更高。

核心结论

  • 在代谢综合征中,缺血性肾病可能参与肾脏疾病的发生。
  • 部分代谢综合征患者可发展出与糖尿病肾病相容的病变,如系膜扩张增加和结节性硬化。

研究设计与样本

  • 研究纳入欧洲肾切除生物样本库(ENBiBA)项目的参与者,共评估157例,其中无MS 49例,MS 108例。
  • MS定义为至少满足以下3项:BMI≥27 kg/m2;糖尿病前期(空腹血糖100-125 mg/dl或HbA1c>5.7%);血压>140/90 mm Hg或使用药物;甘油三酯>150 mg/dl或高密度脂蛋白胆固醇<40(男)/50(女)mg/dl。
  • 排除标准为糖尿病或已知的肾脏疾病病因。

主要发现

  • MS患者较无MS者年龄更大(54±16 vs. 66±11,P<0.0001)。
  • MS患者CKD(eGFR<60 ml/min)更常见:24%(23%) vs. 4%(8%)(P=0.02)。
  • MS患者白蛋白肌酐比更高:10 [4-68] vs. 4.45 [0-27](P=0.05)。
  • MS患者全球硬化(3% [1-7] vs. 7% [3-13],P<0.0001)、结节性硬化、系膜扩张、肾小球肥大、中重度玻璃样变及动脉硬化更频繁(88 [82] vs. 29 [59];83 [77] vs. 30 [61];P<0.05)。
  • 这些血管改变独立于年龄差异。

临床怎么用

  • 对于代谢综合征患者,应关注肾脏结构改变,包括缺血性损伤和类似糖尿病肾病的病变。
  • 代谢综合征患者需监测肾功能(eGFR)和白蛋白尿,以及时发现CKD。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The pathogenesis of renal disease in obesity and metabolic syndrome (MS) is mostly unknown. This is in part because of the limited information about renal morphological changes in these conditions. We evaluated renal histology in subjects with MS and those without MS, who are participants in the European Nephrectomy Biobank (ENBiBA) project. METHODS: MS was defined with at least 3 of the following criteria: (i) body mass index (BMI) ≥27 kg/m2; (ii) prediabetes: fasting glucose of 100-125 mg/dl or HbA1c >5.7%; (iii) systolic or diastolic blood pressure >140/90 mm Hg or the use of medications; and (iv) triglycerides >150 mg/dl or high-density lipoprotein cholesterol <40 (in men) or 50 mg/dl (in women). The absence of these criteria defined patients without MS. Exclusion criteria were diabetes or known causes of renal disease. RESULTS: A total of 157 cases were evaluated: 49 without and 108 with MS. Those with MS were older (54 ± 16 vs. 66 ± 11, P < 0.0001), had more prevalent chronic kidney disease (CKD, estimated glomerular filtration rate [eGFR] <60 ml/min): 24% (23%) versus 4% (8%) (P = 0.02), and had higher albumin-to-creatinine ratio (10 [4-68] vs. 4.45 [0-27], P = 0.05) than those without MS. Global sclerosis (3% [1-7] vs. 7% [3-13], P < 0.0001), nodular sclerosis, mesangial expansion, glomerulomegaly; moderate + severe hyalinosis, and arteriosclerosis were more frequent in those with MS than in those without (88 [82] vs. 29 [59]; 83 [77] vs. 30 [61]; P < 0.05). These vascular changes were independent of differences in age. CONCLUSION: In MS, ischemic renal disease may play a role in renal disease. In addition, some patients may develop lesions compatible with diabetic nephropathy such as increased mesangial expansion and nodular sclerosis. Further analyses are needed to study the consequences of the pandemic of obesity on renal health.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Rodríguez R, Hornum M, Rodríguez Rodríguez AE, et al. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia. Kidney Int Rep. 2024. PMID: 38707823. doi:10.1016/j.ekir.2024.02.1403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。